In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...

Novartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in the US, which accounts for around half its sales. The Swiss pharma group ...

Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s ...